- Excellent financial health (Piotroski 8/9)
- Healthy interest coverage ratio of 28.8x
- Lower volatility than the market (beta 0.08)
High volatility in Astellas Pharma, Inc. stock price on Friday which ended trading at $12.85
(Updated on Jul 10, 2026)
No changes to the price of Astellas Pharma, Inc. stock on the last trading day (Friday, 10th Jul 2026). During the last trading day the stock fluctuated 13.62% from a day low at $12.85 to a day high of $14.60. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -15.57% during the next 3 months and, with a 90% probability hold a price between $9.36 and $11.86 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
ALPMF Signals & Forecast
There are mixed signals in the stock today. The Astellas Pharma, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $13.72 and $13.88. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Wednesday, June 24, 2026, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume gained on the last day while the price remained unchanged. This is not a classical divergence, but the stock should be watched more closely at it may be a "turning point". The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Astellas Pharma, Inc. stock
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.75 between high and low, or 13.62%. For the last week, the stock has had daily average volatility of 6.85%.
Our recommended stop-loss: $12.06 (-6.18%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 11 days ago.)
Trading Expectations (ALPMF) For The Upcoming Trading Day Of Monday 13th
For the upcoming trading day on Monday, 13th we expect Astellas Pharma, Inc. to open at $13.43, and during the day (based on 14 day Average True Range), to move between $12.40 and $13.30, which gives a possible trading interval of +/-$0.91 (+/-7.34%) up or down from last closing price. If Astellas Pharma, Inc. takes out the full calculated possible swing range there will be an estimated 7.34% move between the lowest and the highest trading price during the day.
With no support below and resistance from accumulated volume @ $13.75, some $0.90 (7.00%) from the current price of $12.85, our system finds the risk reward not very attractive.
Dividend Warning For ALPMF
Dividend coming up for ALPMF: Ex-dividend date (Tuesday 29th September, 2026) is 79 days away. The dividend is $0.200.Is Astellas Pharma, Inc. stock A Buy?
Astellas Pharma, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.
Current score:
0.000
Hold/Accumulate
Upgraded
Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.
Predicted Fair Opening Price
Predicted fair opening price on July 13, 2026 - $13.43 ( 4.54%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
ALPMF Performance
Trading levels for ALPMF
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 15.18 | 18.16% |
| R2 | 14.51 | 12.96% |
| R1 | 14.10 | 9.74% |
| Price | 12.85 | |
| S1 | 12.76 | -0.663% |
| S2 | 12.35 | -3.88% |
| S3 | 11.68 | -9.08% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 14.96 | 16.42% |
| R2 | 14.26 | 10.97% |
| R1 | 13.75 | 7.00% |
| Price | 12.85 | |
| S1 | 0 | - |
| S2 | 0 | - |
| S3 | 0 | - |
ALPMF Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Mar 30, 2027 | Mar 30, 2027 | Mar 30, 2027 | $0.200 | 1.28% |
| 2 | Sep 29, 2026 | Sep 29, 2026 | Sep 29, 2026 | $0.199 | 1.38% |
| 3 | Apr 25, 2025 | Mar 31, 2026 | Mar 31, 2026 | $0.271 | 2.84% |
| 4 | Apr 25, 2025 | Sep 30, 2025 | Sep 30, 2025 | $0.271 | 2.84% |
| 5 | Sep 29, 2025 | Sep 29, 2025 | Sep 29, 2025 | $0 | 0% |
FAQ
Click here for our free guide on how to buy Astellas Pharma, Inc. Stock.
Buy ALPMF